Are age-related neurodegenerative diseases linked with various types of magnesium depletion?

Magnesium Research

Volumn 10, Issue 4, 1997, Pages 339-353

  Durlach, Jean ^a   Bac, Pierre ^b   Durlach, Vincent ^c   Durlach, Anne ^d   Bara, Michel ^f   Guiet Bara, Andrée ^e  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d HÔPITAL MAISON BLANCHE   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; MAGNESIUM DEFICIENCY; PARKINSON DISEASE; REVIEW;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 0031307181     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Dawson, Jr., R., Beal, M.F., Bondy, S.C., Di Monte, D.A & Isom, G.E (1995): Excitotoxins, aging and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 134, 1-17.
2. Allen, C.N., Spencer, P.S. & Carpenter, D.O. (1993): β-N-methylamino-L- alanine in the presence of bicarbonate is an agonist at non-N-methyl-D-aspartate-type receptors. Neuroscience 54, 567-574.
3. Calne, D.B., Eisen, A., McGeer, E. & Spencer, P. (1986): Alzheimer's disease, Parkinson's s disease and motoneuron disease: abiotropic interactions between ageing and environment? Lancet II, 1067-1070.
4. Spencer, P.S., Kisby, G.E. & Ludolph, A.C. (1991): Slow toxins, biologic markers and long-latency neurodegenerative disease in the Western Pacific region. Neurology 41 (Suppl.2), 62-66.
5. Lewin, R. (1987): Environmental hypothesis for brain diseases strengthened by new data. Science 237, 483-484.
6. Spencer, P.S., Nunn, P.B., Hugon, J., Ludolph, A.C., Ross, S.M., Roy, D.N. & Robertson, R.C. (1987): Guam amyotrophic lateral sclerosis-Parkinsonism-Dementia linked to a plant excitant neurotoxin. Science 237, 517-522.
7. Hirano, A., Malamud, N. & Kurland, L.T. (1961): Parkinsonism-dementia complex an endemic disease on the island of Guam II. Pathological features. Brain 84, 662-679.
8. Gajdusek, D.C. & Salazar, A.M. (1982): Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of the West New Guinea. Neurology 32, 107-126.
9. Reed, D., Labarthe, D., Chen, K.M. & Stallones, R. (1987): A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am. J. Epidemiol. 125, 92-100.
10. Plato, C.C., Reed, D.M., Elizan, T.S. & Kurland, L.T. (1967): Amyotrophic lateral sclerosis/ parkinsonism-dementia complex of Guam. Am. J. Hum. Genet. 19, 617-632.
11. Plato, C.C., Cruz, M.T. & Kurland, L.T. (1969): Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Am. J. Hum. Genet. 21, 133-141.
12. Plato, C.C., Garutto, R.M., Fox, K.M. & Gajdusek, D.C. (1986): Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam - a 25 year prospective case-control study. Am. J. Epidemiol. 124, 643-656.
13. Zhang, Z.K., Anderson, D.W. & Mantel, N. (1990): Geographic patterns of parkinsonism-dementia complex on Guam. Arch. Neurol. 47, 1069-1074.
14. Gibbs Jr., C.J. & Gajdusek, D.C.( 1982): An update on long term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism-dementia and Parkinson's disease. In Human motor neuron diseases, ed. L.P. Roland, pp. 343-353. New York: Raven Press.
15. Kurland, L.T. & Molgaard, L.A. (1982): Guamanian ALS: hereditary or acquired? In: Human motor neuron diseases, ed. L.P. Roland, pp. 165-177. New York: Raven Press.
16. Spencer, P.S., Allen, C.N., Kisby, G.E. & Ludolph, A.C. (1994): On the etiology and pathogenesis of chemically induced neurodegenerative disorders. Neurobiol. Aging 15, 265-267.
17. Haque, A., Hossain, M., Wouters, G. & Lambein, F. (1996): Epidemiological study of lathyrism in northwestern districts of Bangladesh. Neuroepidemiology 15, 83-91.
18. Yase, Y. (1972): The pathogenesis of amyotrophic lateral sclerosis. Lancet II, 292-296.
19. Mitani, K. (1992): Relationship between neurological diseases due to aluminium load, especially amyotrophic lateral sclerosis and magnesium status. Magnes. Res. 5, 203-213.
20. Kihira, T., Yoshida, S., Uebayashi, Y., Wakayama, I. & Yase, Y. (1994): Experimental model of motor neuron disease: oral aluminium neurotoxicity. Biomed. Res. 15, 27-36.
21. Yasui, M., Ota, K. & Garruto, R.M. (1995): Effects of calcium-deficient diets in the central nervous system and bones of rats. Neurotoxicology 16, 511-517.
22. Kihira, T., Yoshida, S., Mitani, K., Yasui, M. & Yase, Y. (1993): ALS in the Kii Peninsula of Japan, with special reference to neurofibrillary tangles and aluminium. Neuropathol. 13, 125-136.
23. Kihira, T., Yoshida, S., Komoto, J., Wakayama, I. & Yase, Y. (1995): Aluminum-induced model of motor neuron degeneration: subperineurial injection of aluminum in rabbits. Neurotoxicol. 16, 413-424.
24. Yasui, M., Ota, K. & Yoshida, M. (1997): Effects of low Ca and Mg dietary intake on the central nervous system of rats and calcium-magnesium related disorders in the amyotrophic lateral sclerosis focus in the Kii peninsula of Japan. Magnes. Res. 10, 39-49.
25. Durlach, J. & Bac, P. (1997): Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Mineral and metal neurotoxicology, eds. M. Yasui, M.J. Strong, K. Ota & M.A. Verity, pp. 201-210. Boca Raton: CRC Press.
26. Durlach, J., Bac, P., Durlach, V., Bara, M. & Guiet-Bara, A. (1997): Neurotic, neuromuscular and autonomic nervous forms of magnesium imbalance. Magnes. Res. 10, 169-195.
27. Yasui, M., Yase, Y., Ota, K. & Garruto, R.M. (1991): Evaluation of Mg, Ca and Al metabolism in rats and monkeys maintained on Ca deficient diets. Neurotoxicology 12, 603-614.
28. Landfield, P.W., Thibault, O., Mazzanti, M.L., Porter, N.M. & Kerr, D.S. (1992): Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. J. Neurobiol. 23, 1247-1260.
29. Rayssiguier, Y., Durlach, J., Gueux, E, Rock, E. & Mazur, A. (1993): Magnesium and ageing. I. Experimental data: importance of oxydative damage. Magnes. Res. 6, 369-378.
30. Durlach, J., Durlach, V., Bac, P, Rayssiguier, Y., Bara, M. & Guiet-Bara, A. (1993): Magnesium and ageing. II. Clinical data. Aetioiogical mechanisms and pathophysiological consequences of the magnesium deficit in elderly patients. Magnes. Res. 6, 379-394.
31. Couratier, P., Sindou, P., Tabaraud, F., Diop, A.G., Spencer, P.S. & Hugon, J. (1995): Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists. Neurodegeneration 4, 33-41.
32. Schulte, S., Müller, W.E. & Friedberg, K.D. (1995): In vitro and in vivo effects of lead on specific 3H-PN 200-110 binding to dihydropyridine receptors in the frontal cortex of the mouse brain. Toxicology 97, 113-121.
33. Bac, P., Herrenknecht, C., Pages, N., Dupont, C. & Durlach, J. (1996) Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium deficient rats. I. Comparative study of various magnesium salts. Magnes. Res. 9, 281-292.
34. Tamaru, M., Yoneda, Y., Ogita, K., Shimizu, J. & Nagata, Y. (1991): Age related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 542, 83-90.
35. Dawson Jr., R. & Wallace, D.R. (1992): Kainic acid-induced seizures in aged rats: neurochemical correlates. Brain Res. Bull. 29, 459-468.
36. Ahlskog, J.E., Waring, S.C., Kurland, L.T., Petersen, R.C., Moyer, T.P., Harmsen, W.S., Maraganore, D.M., O'Brien, P.C., Esteban-Santillan, C. & Bush, V. (1995): Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology 45, 1340-1344.
37. Glick, J.L. (1990): Dementias: the role of magnesium deficiency and an hypothesis concerning the pathogenesis of Alzheimer's disease. Med. Hypotheses 31, 211-225.
38. Durlach, J. (1990): Magnesium depletion and Alzheimer's disease. Magnes. Res. 3, 217-218.
39. Borella, P., Giardino, A., Neri, M. & Andermarker, E. (1990): Mg and K status in elderly subjects with and without dementia of the Alzheimer type. Magnes. Res. 3, 283-289.
40. Jolly, D.H., Poitrinal, P., Millart, H., Kariger, E., Blanchard, F., Collery, P. & Choisy, H. (1993): Blood, zinc, copper, magnesium, calcium, aluminum and manganese concentrations in patients with and without Alzheimer type dementia. Trace Elements Med. 10, 192-195.
41. Yasui, M., Kihira, T. & Ota, K. (1992): Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology 13, 593-600.
42. Calne, D.B., Chu, N.S., Huang, C.C., Lu, C.S. & Olanow, W. (1994): Manganism and idiopathic Parkinsonism: similarities and differences. Neurology 44, 1583-1586.
43. Lai, J.C.K., Chan, A.W.K., Minski, M.J. & Lim, L. (1997): Relationship between manganese and other minerals. In: eds. M. Yasui, M.J. Strong, K. Ota & M.A. Verity, pp. 297-303. Boca Raton: CRC Press.
44. Wolters, E.C. (1997): Manganese-induced Parkinsonism. In: eds. M. Yasui, M.J. Strong, K. Ota & M.A. Verity, pp. 319-325. Boca Raton: CRC Press.
45. Durlach, J. (1995): Editorial policy of magnesium research: general considerations on the quality criteria for biomedical papers and some complementary guidelines for the contributors to Magnesium Research. Magnes. Res. 8, 191-206.
46. 2+. Scand. J. Clin. Lab. Invest. 54 (Suppl. 217), 7781.
47. Yasui, M. & Ota, K. (1992): Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes. Res. 5, 295-302.
48. Purdey, M. (1994): Are organophosphate pesticides involved in the causation of bovine spongiform encephalopathy (BSE)? Hypothesis based upon a literature review and limited trials on BSE cattle. J. Nutr. Med. 4, 43-82.
49. Purdey, M. (1996): The UK epidemic of BSE: slow virus or chronic pesticide-initiated modification of the prion protein? Part 1: Mechanisms of a chemically induced pathogenesis/transmissibility. Med. Hypotheses 46, 429-443.
50. Purdey, M. (1996): The UK epidemic of BSE: slow virus or chronic pesticide-initiated modification of the prion protein? Part 2: An epidemiological perspective. Med. Hypotheses 46, 445-454.
51. Janka, Z. (1992): Significance of magnesium in functioning of the nervous system. In: Magnesium in biological systems. eds. T. Fazekas, B. Selmeczi & P. Stefanovits, pp. 212-221. Budapest: Akademia Kiado.
52. Lassmann, H., Brunner, C., Bradl, M. & Linington, C. (1988): Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. 75, 566-576.
53. Chambron, J., Namer, I.J., Steibel, J. Gounot, D. & Armspach, J.-P. (1994): Etude par imagerie de résonance magnétique du rôle de la barrière hémato-encéphalique dans la pathogénèse de l'encéphalomyélite allergique expérimentale: applications à la sclérose en plaques. Bull. Acad. Natle. Med. 178, 1647-1665.
54. McCreary, P.A., Battifora, H.A., Laing, G.H. & Hass, G.M. (1966): Protective effect of magnesium deficiency on experimental allergic encephalomyelitis in the rat. Proc. Soc. Exper. Biol. Med. 121, 1130-1133.
55. Hass, G.M., McCreary, P.A., Laing, G.H. & Galt, R.M. (1980): Lympho-proliferative and immunologic aspects of magnesium deficiency. In: Magnesium in health and disease, eds. M. Cantin & M.S. Seelig, pp. 185-200. New York: Spectrum.